OGAudit Web3 Research: @BioProtocol $BIO - The Binance Labs and Pfizer Ventures Backed DeSci Platform Where an AI Agent Raised $900K for Longevity Research?
Bio Protocol has been building the financial layer for decentralized science since 2024 founded by the teams behind Molecule and VitaDAO, now integrating AI agents into the biotech research pipeline:
- Bio enables global communities to create user owned research networks that fund and develop biotechnologies from day one with BioDAOs (VitaDAO for longevity, AthenaDAO for women’s health, HairDAO and others) raising capital via Ignition Sales, tokenizing IP into onchain assets and distributing research royalties to BIO stakers.
- BioAgents, launched August 2025 are autonomous AI scientific agents trained on research data. The first Aubrai, trained on Aubrey de Grey’s longevity lab data, generated 1,000+ onchain hypotheses and raised $900,000 in research funding within weeks of launch.
- Bio V2 (AI-native DeSci platform, funded by a $6.9M Maelstrom raise in September 2025) targets deeper AI integration for hypothesis generation, experimental design and automated R&D pipeline management.
Is Binance Labs backing, $6.9M in fresh funding, a live AI bioagent raising $900K for longevity research and Pfizer Ventures ecosystem validation the most credible real world DeSci thesis in crypto or does extreme RSI volatility, an 80M BIO treasury dump, tokenized biotech IP facing an unproven regulatory landscape and 33% supply overhang confirm that BIO’s real value will only emerge when research royalties start flowing to token holders?
Category: Biotech / AI
Coin Name: $BIO
Circulating Supply: 2.22B
Market Cap: $63.47M
Market Cap Rank: #316
OG (Trust) Score: 40.55
OG Score Rank: #129/1125
Reviewed by 10 OG Auditors.
See the Social Audit with Reviews by crypto OG’s and more on the $BIO Coin page: ogaudit(.)com/crypto/bio-protocol-bio
https://t.co/rPnwoObmCB
